检索结果 - Francesco Tovoli
- Showing 1 - 20 results of 27
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool? 由 Matteo Renzulli, Anna Pecorelli, Nicolò Brandi, Stefano Brocchi, Francesco Tovoli, Alessandro Granito, Gianpaolo Carrafiello, Anna Maria Ierardi, Rita Golfieri
出版 2022Artigo -
12
-
13
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept 由 Stefania De Lorenzo, Francesco Tovoli, Maria Aurelia Barbera, Francesca Garuti, Andrea Palloni, Giorgio Frega, Ingrid Garajová, Alessandro Rizzo, Franco Trevisani, Giovanni Brandi
出版 2018Artigo -
14
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients 由 Francesco Tovoli, Luca Ielasi, Andrea Casadei‐Gardini, Alessandro Granito, Francesco Giuseppe Foschi, Giulia Rovesti, Giulia Negrini, Giulia Orsi, Matteo Renzulli, Fabio Piscaglia
出版 2019Artigo -
15
Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma 由 L. Gramantieri, Annapaola Montagner, Andrea Arleo, F. Suzzi, Cristian Bassi, Francesco Tovoli, Mariangela Bruccoleri, Eleonora Alimenti, Francesca Fornari, Massimo Iavarone, M. Negrini, Fabio Piscaglia, Catia Giovannini
出版 2025Artigo -
16
TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma 由 Alessandro Granito, Antonio Facciorusso, Rodolfo Sacco, Laura Bartalena, Cristina Mosconi, Ugo Vittorio, Alberta Cappelli, Matteo Antonino, Francesco Modestino, Nicolò Brandi, Francesco Tovoli, Fabio Piscaglia, Rita Golfieri, Matteo Renzulli
出版 2021Artigo -
17
Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role 由 Stefania De Lorenzo, Francesco Tovoli, Alessandro Mazzotta, Francesco Vasuri, Julien Edeline, Deborah Malvi, Karim Boudjéma, Matteo Renzulli, Heithem Jeddou, Antonietta D’Errico, Bruno Turlin, Matteo Cescon, Thomas Uguen, Alessandro Granito, Astrid Lièvre, Giovanni Brandi
出版 2020Artigo -
18
Liver decompensation in patients with hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab: a real-life study 由 Leonardo Stella, Maria Pallozzi, Lucia Cerrito, Francesco Santopaolo, Francesco Tovoli, Clémence Hollande, Sabrina Sidali, Bernardo Stefanini, Claudia Campani, Elisa Pellegrini, Giuseppe Cabibbo, Fabio Marra, Fabio Piscaglia, Antonio Gasbarrini, Maurizio Pompili, Mohamed Bouattour, Francesca Romana Ponziani
出版 2025Artigo -
19
Benefits, Open questions and Challenges of the use of Ultrasound in the COVID-19 pandemic era. The views of a panel of worldwide international experts 由 Fabio Piscaglia, Federico Stefanini, Vito Cantisani, Paul S. Sidhu, R. Graham Barr, Annalisa Berzigotti, Maria Cristina Chammas, Jean-Michel Correas, Christoph F. Dietrich, Steven B. Feinstein, Pintong Huang, Christian Jenssen, Yuko Kono, Masatoshi Kudo, Ping Liang, Andrej Lyshchik, Christian Nolsøe, Xyaoyan Xie, Francesco Tovoli
出版 2020Artigo -
20
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study 由 Masatoshi Kudo, Richard S. Finn, Shukui Qin, Kwang‐Hyub Han, Kenji Ikeda, Ann‐Lii Cheng, Arndt Vogel, Francesco Tovoli, Kazuomi Ueshima, Hiroshi Aikata, Carlos López, Marc Pracht, Zhiqiang Meng, Bruno Daniele, Joong‐Won Park, D. Palmer, Toshiyuki Tamai, Kenichi Saito, Corina E. Dutcus, Riccardo Lencioni
出版 2022Artigo
相关主题
Medicine
Internal medicine
Hepatocellular carcinoma
Gastroenterology
Oncology
Cancer
Disease
Sorafenib
Immunology
Immunotherapy
Pathology
Adverse effect
Environmental health
Nivolumab
Surgery
Biology
Cancer research
Chemotherapy
Confidence interval
Fatty liver
Population
Atezolizumab
Bevacizumab
Family medicine
Gluten
Lenvatinib
Multivariate analysis
Antibody
Biochemistry
Carcinoma